Literature DB >> 6355187

Influence of augmented Hageman factor (Factor XII) titers on the cryoactivation of plasma prorenin in women using oral contraceptive agents.

E M Gordon, J Douglas, O D Ratnoff.   

Abstract

Prolonged cold storage of plasma may induce the conversion of plasma prorenin (inactive renin) to renin. This phenomenon is exaggerated in oral contraceptive (OC) users; the titer of Hageman factor (HF, Factor XII) in OC users is higher than in nonusers. The present study relates these observations. The increment in plasma renin activity (PRA) during cold storage, as measured by generation of angiotensin I, correlated strongly with the initial plasma titer of HF. Increasing the HF titer of nonusers to that observed in OC users by addition of purified HF increased cold-induced PRA at least twofold, while reducing the plasma HF titer of OC users correspondingly decreased cold-induced PRA. Thus, in OC users, the enhanced conversion of plasma prorenin to renin during cold storage reflects the elevated plasma titer of HF.

Entities:  

Keywords:  Biology; Blood Coagulation Effects; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods--side effects; Ethinyl Estradiol; Ethynodiol Diacetate; Examinations And Diagnoses; Family Planning; Hematological Effects; Hemic System; Homeostasis; Laboratory Examinations And Diagnoses; Laboratory Procedures; Mestranol; Norethindrone; Norgestrel; Oral Contraceptives--side effects; Physiology; Renin-angiotensin-aldosterone Effects; Reproductive Control Agents

Mesh:

Substances:

Year:  1983        PMID: 6355187      PMCID: PMC370472          DOI: 10.1172/JCI111143

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Angiotensins I and II, active and inactive renin, renin substrate, renin activity, and angiotensinase in human liquor amnii and plasma.

Authors:  S L Skinner; E J Cran; R Gibson; R Taylor; W A Walters; K J Catt
Journal:  Am J Obstet Gynecol       Date:  1975-03-01       Impact factor: 8.661

2.  Increased renin activity after cold storage of human plasma.

Authors:  D H Osmond; L J Ross; K D Scaiff
Journal:  Can J Physiol Pharmacol       Date:  1973-09       Impact factor: 2.273

3.  Inhibition of the adsorption of Hagemen factor (Factor XII) to glass by normal human plasma.

Authors:  H Saito; O D Ratnoff; V H Donaldson; G Haney; J Pensky
Journal:  J Lab Clin Med       Date:  1974-07

4.  Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.

Authors:  C D Forbes; J Pensky; O D Ratnoff
Journal:  J Lab Clin Med       Date:  1970-11

5.  Plasma prorenin: cryoactivation and relationship to renin substrate in normal subjects.

Authors:  J E Sealey; C Moon; J H Laragh; M Alderman
Journal:  Am J Med       Date:  1976-11       Impact factor: 4.965

6.  Studies on plasma thromboplastin antecedent (factor XI), PTA deficiency and inhibition of PTA by plasma: pharmacologic inhibitors and specific antiserum.

Authors:  C D Forbes; O D Ratnoff
Journal:  J Lab Clin Med       Date:  1972-01

7.  The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).

Authors:  C G Cochrane; K D Wuepper
Journal:  J Exp Med       Date:  1971-10-01       Impact factor: 14.307

8.  Inactive renin in human plasma.

Authors:  F H Derkx; J M von Gool; G J Wenting; R P Verhoeven; A J Man in 't Veld; M A Schalekamp
Journal:  Lancet       Date:  1976-09-04       Impact factor: 79.321

9.  Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

Authors:  T S Zimmerman; O D Ratnoff; A E Powell
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

10.  The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor.

Authors:  O D Ratnoff; J Pensky; D Ogston; G B Naff
Journal:  J Exp Med       Date:  1969-02-01       Impact factor: 14.307

View more
  1 in total

1.  Mitogenic effects of coagulation factor XII and factor XIIa on HepG2 cells.

Authors:  K T Schmeidler-Sapiro; O D Ratnoff; E M Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.